# OnCo record genomic-testing-biliary-uk (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/genomic-testing-biliary-uk/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "genomic-testing-biliary-uk" ;
  schema:name "HER2 and genomic testing for biliary cancer on the NHS"@en ;
  schema:description "Asking for HER2 testing and a tumour gene panel at diagnosis of advanced gallbladder cancer is reasonable, because about one in ten tumours is HER2-positive on staining (more carry a HER2 gene change) and a HER2 antibody is now funded on the NHS; the test is arranged by your hospital team on a sample already taken."@en ;
  schema:url <https://onco.cc/terms/genomic-testing-biliary-uk/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://www.nhs.uk/tests-and-treatments/genetic-and-genomic-testing/>, <https://ammf.org.uk/molecular-profiling-booklet-and-video/>, <https://www.gov.uk/government/news/mhra-approves-zanidatamab-ziihera-for-the-treatment-of-biliary-tract-cancer>, <https://www.esmo.org/for-patients/patient-guides/biliary-tract-cancer-a-guide-for-patients> ;
  onco:cancers <https://onco.cc/cancers/gallbladder/> ;
  onco:technologies <https://onco.cc/technologies/cgp/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/her2-testing-assays/>, <https://onco.cc/drugs/zanidatamab/> ;
  onco:terms <https://onco.cc/terms/genomic-profiling/>, <https://onco.cc/terms/tumour-agnostic/>, <https://onco.cc/terms/msi/> .